Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine and cytarabine with G-CSF priming for resistant AML
NCT00529880Phase 2Unknown
- Sponsor
- Japan Adult Leukemia Study Group
- Start
- Dec 2004
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, cytarabine in acute myeloid leukemia (AML), sponsored by Japan Adult Leukemia Study Group. Status: unknown.
02
Drugs
fludarabinecytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00529880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529880.